Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Ryerson

Showing results (31-40 of 326) with videos related to

Pageof 33
Sort By:
The Lancet. Respiratory Medicine|January 14, 2023
Integrating morphology and treatable traits into the management of ILDDaniel-Costin Marinescu, Christopher J Ryerson
Chest|May 10, 2025
POINT: Should the Progressive Pulmonary Fibrosis Clinical Practice Guideline Be Adopted for Clinical Practice? YesDaniel-Costin Marinescu, Christopher J Ryerson
American Journal of Respiratory and Critical Care Medicine|October 15, 2016
What Gets Measured Gets Managed: Daily Home Spirometry in Idiopathic Pulmonary FibrosisKerri A Johannson, Christopher J Ryerson
Current Opinion in Pulmonary Medicine|July 18, 2014
Acute exacerbations complicating interstitial lung diseaseChristopher J Ryerson, Harold R Collard
Respirology (Carlton, Vic.)|September 4, 2020
A closer look at the multidisciplinary interstitial lung disease clinic: Who, what and howJapnam S Grewal, Christopher J Ryerson
Current Opinion in Pulmonary Medicine|July 24, 2020
Frailty in patients with interstitial lung diseaseSabina A Guler, Christopher J Ryerson
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Response to Rajan et al.: Malignancies that are ILDsKerri A Johannson, Christopher J Ryerson
The European Respiratory Journal|April 1, 2023
Design considerations and implications of findings on progressive pulmonary fibrosis from the prospective Canadian Registry for Pulmonary FibrosisChristopher J Ryerson, Nathan Hambly, Martin Kolb
The European Respiratory Journal|April 2, 2026
Tissue-based categorisation of fibrotic interstitial pneumonias: when early diagnosis can make the differenceVenerino Poletti, Christopher J Ryerson, Sara Piciucchi
The Lancet. Respiratory Medicine|February 9, 2020
Real-world appropriateness of imaging severity thresholds in interstitial lung disease clinical trialsChristopher J Ryerson, Nicole S L Goh
Pageof 33

Showing results (31-40 of 326) with videos related to

Sort By:
Pageof 33
The Lancet. Respiratory Medicine|January 14, 2023
Integrating morphology and treatable traits into the management of ILDDaniel-Costin Marinescu, Christopher J Ryerson
Chest|May 10, 2025
POINT: Should the Progressive Pulmonary Fibrosis Clinical Practice Guideline Be Adopted for Clinical Practice? YesDaniel-Costin Marinescu, Christopher J Ryerson
American Journal of Respiratory and Critical Care Medicine|October 15, 2016
What Gets Measured Gets Managed: Daily Home Spirometry in Idiopathic Pulmonary FibrosisKerri A Johannson, Christopher J Ryerson
Current Opinion in Pulmonary Medicine|July 18, 2014
Acute exacerbations complicating interstitial lung diseaseChristopher J Ryerson, Harold R Collard
Respirology (Carlton, Vic.)|September 4, 2020
A closer look at the multidisciplinary interstitial lung disease clinic: Who, what and howJapnam S Grewal, Christopher J Ryerson
Current Opinion in Pulmonary Medicine|July 24, 2020
Frailty in patients with interstitial lung diseaseSabina A Guler, Christopher J Ryerson
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Response to Rajan et al.: Malignancies that are ILDsKerri A Johannson, Christopher J Ryerson
The European Respiratory Journal|April 1, 2023
Design considerations and implications of findings on progressive pulmonary fibrosis from the prospective Canadian Registry for Pulmonary FibrosisChristopher J Ryerson, Nathan Hambly, Martin Kolb
The European Respiratory Journal|April 2, 2026
Tissue-based categorisation of fibrotic interstitial pneumonias: when early diagnosis can make the differenceVenerino Poletti, Christopher J Ryerson, Sara Piciucchi
The Lancet. Respiratory Medicine|February 9, 2020
Real-world appropriateness of imaging severity thresholds in interstitial lung disease clinical trialsChristopher J Ryerson, Nicole S L Goh
Pageof 33